Targovax to present at Biologics World Nordic 2018
Oslo, Norway, 27 February 2018 - Targovax ASA (OSE: TRVX), a clinical stage company focused on developing immuno-oncology therapies to target solid tumors, announces that the Company will present at the following conference: Biologics World Nordic 2018Date: 28 February 2018Presenter: Einar Jonsbu, Dir. Biopharm. CMC DevelopmentPresentation time: 15:40 CETVenue: Copenhagen Title: Case Study: CMC outsourcing in small virtual biotech company for antigen-specific cancer immunotherapyThe presentation will be available to download at www.targovax.com following these events. For